Tanke Biosciences Cash And Equivalents vs. Current Ratio
| TNBI Stock | USD 0.01 0.00 0.00% |
For Tanke Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tanke Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tanke Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tanke Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tanke Biosciences over time as well as its relative position and ranking within its peers.
Tanke |
Tanke Biosciences Current Ratio vs. Cash And Equivalents Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tanke Biosciences's current stock value. Our valuation model uses many indicators to compare Tanke Biosciences value to that of its competitors to determine the firm's financial worth. Tanke Biosciences is currently regarded as top stock in cash and equivalents category among its peers. It also is currently regarded as top stock in current ratio category among its peers . The ratio of Cash And Equivalents to Current Ratio for Tanke Biosciences is about 3,161,491 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tanke Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tanke Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Tanke Current Ratio vs. Cash And Equivalents
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Tanke Biosciences |
| = | 5.09 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Tanke Biosciences |
| = | 1.61 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Tanke Current Ratio Comparison
Tanke Biosciences is currently under evaluation in current ratio category among its peers.
Tanke Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tanke Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tanke Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Tanke Biosciences' change in net profit over the period of time. It can combine multiple indicators of Tanke Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.
Tanke Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tanke Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tanke Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tanke Biosciences' important profitability drivers and their relationship over time.
Use Tanke Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tanke Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tanke Biosciences will appreciate offsetting losses from the drop in the long position's value.Tanke Biosciences Pair Trading
Tanke Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Tanke Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tanke Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tanke Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tanke Biosciences to buy it.
The correlation of Tanke Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tanke Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tanke Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tanke Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tanke Biosciences position
In addition to having Tanke Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Tanke Pink Sheet
To fully project Tanke Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tanke Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tanke Biosciences' income statement, its balance sheet, and the statement of cash flows.